From Liston Street Pulse:
Shares of Lexicon Pharmaceuticals Inc. (LXRX), a biopharmaceutical company engaged in the discovery and development of breakthrough treatments for human diseases, have skyrocketed in trading today after the company announced that its LX4211 achieved positive results in Type 2 Diabetes patients with renal impairment. At last check, LXRX shares were […]
The post Lexicon Pharmaceuticals Shares Surge on Positive Study Results appeared first on Liston Street Pulse.
Created by Stock Researching | Dec 13, 2016
Created by Stock Researching | Dec 04, 2016
Created by Stock Researching | Dec 02, 2016
Created by Stock Researching | Nov 19, 2016
Created by Stock Researching | Nov 10, 2016
Created by Stock Researching | Oct 05, 2015